Αποτελέσματα Αναζήτησης
6 ημέρες πριν · The recommended vaccine and number of 2024–2025 COVID-19 vaccine doses are based on age and vaccination history. COVID-19 vaccination guidance for people who are moderately or severely immunocompromised is detailed in Table 2. Table 1. Routine COVID-19 vaccination schedule, October 31, 2024.
15 Φεβ 2023 · The BNT162b2 vaccine (Pfizer–BioNTech) has U.S. licensure for immunization against Covid-19 in persons 12 years of age or older and emergency use authorization in children 5 to 11 years of age...
24 Νοε 2021 · It examines the role of COVID-19 vaccines in children and adolescents in the global context of inequitable vaccine distribution and access across countries at a time when many countries have not yet achieved high vaccine coverage rates in the highest and high priority-use groups. Background.
25 Νοε 2021 · EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11. The vaccine, developed by BioNTech and Pfizer, is already approved for use in adults and children aged 12 and above.
20 Μαΐ 2022 · When will a COVID-19 vaccine be approved for children under the age of 5? Pfizer and Moderna are both conducting studies of their vaccines in children ages 6 months to 4 years. Pfizer officials in December said they would expand clinical trials to include a third dose of the 3-microgram vaccine for children ages 2 to 4.
28 Μαΐ 2021 · EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12 to 15. The vaccine is already approved for use in adults and adolescents aged 16 and above.
9 Ιουλ 2022 · A recent US study reported cumulative hospitalisation rates of 19·1 per 100 000 infections among unvaccinated children and 9·2 per 100 000 infections among vaccinated children aged 5–11 years during December, 2021, to February, 2022. 5 These studies highlight the low risk of severe outcomes irrespective of vaccination status in children ...
